110 related articles for article (PubMed ID: 12699362)
1. Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.
Chertova E; Crise BJ; Morcock DR; Bess JW; Henderson LE; Lifson JD
Curr Mol Med; 2003 May; 3(3):265-72. PubMed ID: 12699362
[TBL] [Abstract][Full Text] [Related]
2. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
Arthur LO; Bess JW; Chertova EN; Rossio JL; Esser MT; Benveniste RE; Henderson LE; Lifson JD
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S311-9. PubMed ID: 9814959
[TBL] [Abstract][Full Text] [Related]
3. Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.
Morcock DR; Thomas JA; Gagliardi TD; Gorelick RJ; Roser JD; Chertova EN; Bess JW; Ott DE; Sattentau QJ; Frank I; Pope M; Lifson JD; Henderson LE; Crise BJ
J Virol; 2005 Feb; 79(3):1533-42. PubMed ID: 15650179
[TBL] [Abstract][Full Text] [Related]
4. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs.
Frank I; Piatak M; Stoessel H; Romani N; Bonnyay D; Lifson JD; Pope M
J Virol; 2002 Mar; 76(6):2936-51. PubMed ID: 11861860
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
Rossio JL; Esser MT; Suryanarayana K; Schneider DK; Bess JW; Vasquez GM; Wiltrout TA; Chertova E; Grimes MK; Sattentau Q; Arthur LO; Henderson LE; Lifson JD
J Virol; 1998 Oct; 72(10):7992-8001. PubMed ID: 9733838
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of respiratory syncytial virus by zinc finger reactive compounds.
Boukhvalova MS; Prince GA; Blanco JC
Virol J; 2010 Jan; 7():20. PubMed ID: 20102602
[TBL] [Abstract][Full Text] [Related]
7. Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.
Fitzgerald W; Sylwester AW; Grivel JC; Lifson JD; Margolis LB
J Virol; 2004 Jul; 78(13):7061-8. PubMed ID: 15194782
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts.
Graham DR; Chertova E; Hilburn JM; Arthur LO; Hildreth JE
J Virol; 2003 Aug; 77(15):8237-48. PubMed ID: 12857892
[TBL] [Abstract][Full Text] [Related]
9. 2,2'-Bispyridyl disulfide rapidly induces intramolecular disulfide bonds in peptides.
Maruyama K; Nagasawa H; Suzuki A
Peptides; 1999; 20(7):881-4. PubMed ID: 10477090
[TBL] [Abstract][Full Text] [Related]
10. Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling.
Raviv Y; Viard M; Bess J; Blumenthal R
Virology; 2002 Feb; 293(2):243-51. PubMed ID: 11886244
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.
Rutebemberwa A; Bess JW; Brown B; Arroyo M; Eller M; Slike B; Polonis V; McCutchan F; Currier JR; Birx D; Robb M; Marovich M; Lifson JD; Cox JH
AIDS Res Hum Retroviruses; 2007 Apr; 23(4):532-42. PubMed ID: 17506610
[TBL] [Abstract][Full Text] [Related]
12. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
[TBL] [Abstract][Full Text] [Related]
13. Changes of polymerization and conformation of hemoglobin S induced by thiol reagents.
Garel MC; Caburi-Martin J; Domenget C; Kister J; Craescu CT; Poyart C; Beuzard Y
Biochim Biophys Acta; 1990 Nov; 1041(2):133-40. PubMed ID: 2265199
[TBL] [Abstract][Full Text] [Related]
14. Labeling of cysteine 231 in acetylcholinesterase from Torpedo nobiliana by the active-site directed reagent, 1-bromo-2-[14C] pinacolone. Effects of 2,2'-dipyridyl disulfide and other sulfhydryl reagents.
Salih E; Howard S; Chishti SB; Cohen SG; Liu WS; Cohen JB
J Biol Chem; 1993 Jan; 268(1):245-51. PubMed ID: 8416933
[TBL] [Abstract][Full Text] [Related]
15. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
[TBL] [Abstract][Full Text] [Related]
16. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions.
Sylwester AW; Grivel JC; Fitzgerald W; Rossio JL; Lifson JD; Margolis LB
J Virol; 1998 Nov; 72(11):9345-7. PubMed ID: 9765486
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.
Raviv Y; Viard M; Bess JW; Chertova E; Blumenthal R
J Virol; 2005 Oct; 79(19):12394-400. PubMed ID: 16160166
[TBL] [Abstract][Full Text] [Related]
19. Actions of sulfhydryl reagents on single ryanodine receptor Ca(2+)-release channels from sheep myocardium.
Eager KR; Roden LD; Dulhunty AF
Am J Physiol; 1997 Jun; 272(6 Pt 1):C1908-18. PubMed ID: 9227420
[TBL] [Abstract][Full Text] [Related]
20. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.
Gorelick RJ; Benveniste RE; Gagliardi TD; Wiltrout TA; Busch LK; Bosche WJ; Coren LV; Lifson JD; Bradley PJ; Henderson LE; Arthur LO
Virology; 1999 Jan; 253(2):259-70. PubMed ID: 9918884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
